Analgesics is expected to see a slightly slower overall current value growth rate in 2020 than was seen in all other years of the review period. However, performances are expected to vary widely between categories, with systemic analgesics set to see stronger current value growth than in the previous few years, and topical analgesics/anaesthetic expected to turn to decline. This is a significant change from previous years, as many Indonesians had become concerned about consuming products contain...

ALSO READ: http://www.marketwatch.com/story/global-light-dependent-resistors-market-size-share-value-and-competitive-landscape-2026-2021-03-13

Euromonitor International's Analgesics in Indonesia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

ALSO READ: http://www.marketwatch.com/story/global-gas-cooktop-market-outlook-industry-analysis-and-prospect-2021-2021-03-14

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

ALSO READ: http://www.marketwatch.com/story/global-golf-sunglasses-market-size-share-value-and-competitive-landscape-2021-03-14

Table of Contents

Analgesics in Indonesia
Euromonitor International
November 2020

List OF CONTENTS AND TABLES

KEY DATA FINDINGS
2020 IMPACT
Systemic analgesics sees higher growth due to COVID-19
Share growth for e-commerce and chemists/pharmacies due to PSSB measures
Acetaminophen brands Paramex and Bodrex extend their lead
RECOVERY AND OPPORTUNITIES
Rapid return to previous levels of growth in analgesics
Cultural habits will ensure rising demand for topical analgesics/anaesthetic
Menstrual analgesics set to see growth due to the rising number of working women

ALSO READ: http://www.marketwatch.com/story/global-vehicle-suspension-market-size-share-value-and-competitive-landscape-2021-03-16


CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2015-2020
Table 2 Sales of Analgesics by Category: % Value Growth 2015-2020
Table 3 NBO Company Shares of Analgesics: % Value 2016-2020
Table 4 LBN Brand Shares of Analgesics: % Value 2017-2020
Table 5 Forecast Sales of Analgesics by Category: Value 2020-2025
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2020-2025
EXECUTIVE SUMMARY
COVID-19 impact on consumer health
COVID-19 country impact
Company response
Retailing shift
What next for consumer health?

ALSO READ: http://www.marketwatch.com/story/global-electrical-stimulation-devices-esds-professional-market-size-share-value-and-competitive-landscape-2020-2021-03-15


MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
Table 8 Life Expectancy at Birth 2015-2020
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2015-2020
Table 10 Sales of Consumer Health by Category: % Value Growth 2015-2020
Table 11 NBO Company Shares of Consumer Health: % Value 2016-2020
Table 12 LBN Brand Shares of Consumer Health: % Value 2017-2020
Table 13 Distribution of Consumer Health by Format: % Value 2015-2020

….CONTINUED

CONTACT DETAILS :

[email protected]

+44 203 500 2763

+1 62 825 80070

971 0503084105